/imol/l).
immunoreactive PTHrP was demonstrated in an extract of a humoral hypercalcemia of malignancy tumor (6, 7) by radioimmunoassay (RIA) . In 1990, Burtis et al. (8) developed an immunoradiometric assay (IRMA) for PTHrP and an RIA for PTHrP (109-138). and reported that both their assays were useful in the differential diagnosis of hypercalcemia. The value of determining urinary PTHrP (127-141) was also reported (9) . However, the serum PTHrP levels in normal subjects are difficult to measure by these assays, and there have been few reports on the relationship between the clinical course and serum PTHrP level.
Recently, Kasahara et al. (10) developed an RIA kit for PTHrP (109-141) with which we could measure the serum PTHrP concentrations in normal subjects and in patients with various diseases. Here we report data on the serum PTHrP concentrations in patients with héma¬ tologie malignancies or solid tumors who had normal serum creatinine levels, and the relationship between the clinical course and change in serum PTHrP.
Subjects and methods

Subjects
The subjects examined were 167 normal adults (92M, 75F) aged (Fig. 3) . Anti 
